Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shinbaro in Hand Osteoarthritis
NCT01910116Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hand osteoarthritis comparing Shinbaro Arm with Placebo Arm (2 arms). Primary endpoint: AUSCAN Pain Change from Baseline at 4 weeks. Started Sep 2013; status: completed.
02
Drugs
herbal medicine-Jaseng Medical Foundation
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on NCT01910116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910116.